These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 5386819)
41. [Content of sulfhydryl compounds in the serum of patients with rheumatic heart diseases associated with hypertension]. Bobrov VA Vopr Revm; 1977; (4):7-10. PubMed ID: 605575 [No Abstract] [Full Text] [Related]
42. [Effect of xao-ke-zheng fang on blood sugar levels of alloxan diabetic rabbits]. Meng QD Zhong Yao Tong Bao; 1984 Nov; 9(6):33-4. PubMed ID: 6242111 [No Abstract] [Full Text] [Related]
43. Effect of BAL in preventing alloxan-diabetes in rats. TISLOW R; CHESLER A Fed Proc; 1947; 6(1 Pt 2):215. PubMed ID: 20244267 [No Abstract] [Full Text] [Related]
44. Lipid-derived modifications of plasma proteins in experimental and human diabetes. Januszewski AS; Jenkins AJ; Baynes JW; Thorpe SR Ann N Y Acad Sci; 2005 Jun; 1043():404-12. PubMed ID: 16037262 [TBL] [Abstract][Full Text] [Related]
45. [Quantitative analysis of the phospholipid composition of the myocardium in experimental diabetes mellitus: effect of total ischemia]. Dzavadov SA; Eĭiuboa AA; Mamedova LK; Gel'fgat EB; Pogacha G Vopr Med Khim; 1994; 40(2):12-9. PubMed ID: 8160420 [TBL] [Abstract][Full Text] [Related]
46. Dynamical evolution of some biochemical parameters in alloxan diabetes. Milanov S; Popova N Nauchni Tr Vissh Med Inst Sofiia; 1968; 47(4):45-9. PubMed ID: 4243155 [No Abstract] [Full Text] [Related]
47. [Prevention of dithizone diabetes with compounds containing sulfhydryl groups]. Lazaris IaA; Bavel'skiĭ ZE Biull Eksp Biol Med; 1969 Mar; 67(3):40-2. PubMed ID: 5821455 [No Abstract] [Full Text] [Related]
48. [Effects of alloxan diabetes on alpha ketoglutaric acid levels]. Deptula S Acta Pol Pharm; 1970; 27(5):515-6. PubMed ID: 5501748 [No Abstract] [Full Text] [Related]
49. Bauhinia candicans stimulation of glucose uptake in isolated gastric glands of normal and diabetic rabbits. Fuentes O; Alarcón J Fitoterapia; 2006 Jun; 77(4):271-5. PubMed ID: 16690222 [TBL] [Abstract][Full Text] [Related]
50. The bioavailability and pharmacokinetics of mefenamic acid in alloxan-diabetic rabbits. Qamar S; Irfan N; Ahmad M; Jamshaid M; Muzaffar NA Tokai J Exp Clin Med; 1997 Oct; 22(4):163-6. PubMed ID: 9777006 [TBL] [Abstract][Full Text] [Related]
51. [Respiration and glycolysis of rabbit exudate leukocytes under normal conditions and in alloxan diabetes]. Shestakova SA Biull Eksp Biol Med; 1967 Sep; 64(9):61-2. PubMed ID: 5622436 [No Abstract] [Full Text] [Related]
53. In vivo assessment of antidiabetic and antioxidant activities of rosemary (Rosmarinus officinalis) in alloxan-diabetic rabbits. Bakirel T; Bakirel U; Keleş OU; Ulgen SG; Yardibi H J Ethnopharmacol; 2008 Feb; 116(1):64-73. PubMed ID: 18063331 [TBL] [Abstract][Full Text] [Related]
54. [Changes in diameter size and F-actin expression in the myocytes of patients with diabetes and streptozotocin-induced diabetes model rats]. Kawaguchi M; Asakura T; Saito F; Nemoto O; Maehara K; Miyake K; Sugai N; Maruyama Y J Cardiol; 1999 Dec; 34(6):333-9. PubMed ID: 10642930 [TBL] [Abstract][Full Text] [Related]
56. [Concentration of immunoreactive insulin and sulfhydryl groups in the serum of pulmonary tuberculosis patients]. Ershov AI; Sushkin AG; Sharunov SI Probl Tuberk; 1984 May; (5):51-3. PubMed ID: 6377302 [No Abstract] [Full Text] [Related]
57. Modification of cardiac oxidative stress in alloxan-induced diabetic rabbits with repaglinide treatment. Gumieniczek A Life Sci; 2005 Dec; 78(3):259-63. PubMed ID: 16137706 [TBL] [Abstract][Full Text] [Related]